- Boehringer Ingelheim’s pipeline activity: A busy year of dealmaking for the German pharma in 2025
- Greener pastures for biopharma? Biotechs in Ireland causing a stir
- Rethinking infertility treatment: Treating couples, not just women
- Vandria reports VNA-318’s first-in-human data in Alzheimer’s
- Research Triangle Park: A closer look at North Carolina’s burgeoning biotech hub
- Curing cancer: Daiichi Sankyo’s ambitious ADC approach
- Beyond GLP-1s: is there a new wave of metabolic disease treatments?
- Six key obesity deals in 2025
- How to succeed at BIO-Europe: DISCO Pharma takes us behind the scenes
- Twice the punch: The emergence of dual-payload antibody and peptide drug conjugates
- On the fast track to the clinic: early decisions in drug development
- Precision psychiatry is the future of mental healthcare
- Meet Fusix Biotech: 2025 BIO-Europe Startup Spotlight champion revolutionizing oncology
- iGEM Jamboree: leap into the synthetic biology future
- Biosimilars: a vital remedy for Europe’s healthcare challenges
